Holen Sie sich die Stockscreener-App
0.5328
4.86%
-0.0272
Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten
Arcus Biosciences stock falls on public offering announcement - Yahoo Finance Australia
Caribou Biosciences (CRBU) Slides 6.44% to $0.46 as Shares Test Key SupportRVOL Breakout - https://www.siam.in/
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
OLB Group (OLB) Rally Cools After Hours as Shares Tumble 29%: Here's Why - Benzinga
Caribou alarm herd, stock plunges on ‘alternatives’ plan - BioWorld News
OLB Group (OLB) Rally Cools After Hours as Shares Tumble 29%: Here's Why - TradingView
A director receives 14,000 Kyntra Bio (KYNB) stock options with a $6.50 exercise price. - Stock Titan
Caribou Biosciences stock plunges 40% on halt of CAR-T programs - Investing.com
500,000 option-exercise shares are part of an officer's planned sale at Pacific Biosciences (PACB). - Stock Titan
A director converts a stock grant and holds 141,585 Solid Biosciences (SLDB) shares directly. - Stock Titan
Option exercises are part of a CEO's proposed share sale at IDEAYA (Nasdaq: IDYA). - Stock Titan
Constellation Brands Inc (STZ) Stock Price, Quote, News & History - Benzinga
After buying 5,500 shares, Anixa Biosciences (ANIX) CFO holds 50,000 shares directly. - Stock Titan
The NYSE notifies regulators of plans to remove Global Business Travel (NYSE: GBTG) Class A shares. - Stock Titan
Over 5% stake disclosed in Harvard Bioscience (HBIO) - Stock Titan
TuHURA Biosciences (Nasdaq:HURA)Stock Analysis - Simply Wall Street
Caribou Biosciences (NasdaqGS:CRBU) Stock Price - Simply Wall Street
Upstream Bio (UPB) CEO share sale used to cover taxes - Stock Titan
Performance grant hands 4,483 shares to Neurocrine (NBIX) regulatory chief - Stock Titan
Director’s trust at Inhibrx (NASDAQ: INBX) logs four 500-share stock sales - Stock Titan
Caribou Biosciences (CRBU) Loses 19.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - finance.yahoo.com
Anixa Biosciences (NASDAQ: ANIX) CEO lifts stake to 665,000 shares - Stock Titan
Bio-Rad (NYSE: BIO) grants EVP 4,601 RSUs, with shares withheld at $386.11 - Stock Titan
Aquestive Therapeutics (AQST) CEO boosts stake with warrant exercise - Stock Titan
OUTFRONT Media (NYSE: OUT) officer plans $100.9K Rule 144 stock sale - Stock Titan
Here's Why You Should Retain IQVIA Stock in Your Portfolio Now - TradingView
Interpace Biosciences will reduce outstanding shares from ~27.7M to ~5.5M - Stock Titan
Caribou (CRBU) Today: Gains 3.11% to Reach $1.66 at the Close; Key Range: $1.58 and $1.74 Define the Nearby Reference Levels under the Current SnapshotVOLD Alert - vinanet.vn
Caribou (CRBU) Today: Gains 3.11% to Reach $1.66 at the Close; Key Range: $1.58 and $1.74 Define the Nearby Reference Levels under the Current SnapshotVolatility Stop - careplusvn.com
Caribou (CRBU) Today: Gains 3.11% to Reach $1.66 at the Close; Key Range: $1.58 and $1.74 Define the Nearby Reference Levels under the Current SnapshotValue Stock Ideas - siam.in
Caribou (CRBU) Quarterly Figures: EPS Comes in Above Forecast in the Latest Reading; Share Move - vinanet.vn
Caribou (CRBU) Quarterly Figures: EPS Comes in Above Forecast in the Latest Reading; Share Move - vinanet.vn
3i injects cash into Valion Bio (VBIO) under tight ownership cap - Stock Titan
PubMatic (NASDAQ: PUBM) details latest insider stock trade - Stock Titan
Caribou Biosciences (CRBU) Slips 1.86% to $1.58 as Gene-Editing Stock Tests Key Support LevelPut Wall - dars.gov.et
Caribou Biosciences (CRBU) Slips 1.86% to $1.58 as Gene-Editing Stock Tests Key Support LevelDark Pool Prints - vinanet.vn
Caribou Biosciences (CRBU) Slips 1.86% to $1.58 as Gene-Editing Stock Tests Key Support LevelPut Wall - dars.gov.et
Caribou Biosciences (CRBU) Slips 1.86% to $1.58 as Gene-Editing Stock Tests Key Support LevelAAII Bearish - dars.gov.et
Caribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Caribou Biosciences (NASDAQ:CRBU) Price Target Cut to $5.00 by Analysts at Bank of America - MarketBeat
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Caribou Biosciences, Inc. Stock 12‑Month Price Target Cut to $11.86, Implies 636% Upside - TradingView
Caribou Biosciences earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Caribou Biosciences earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Caribou Biosciences (NASDAQ:CRBU) Releases Earnings Results, Beats Expectations By $0.08 EPS - MarketBeat
Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Caribou Biosciences Q2 EPS beats estimate, sales miss - scanx.trade
Form 8K Caribou Biosciences Inc For: 13 August By Investing.com - Investing.com Australia
Caribou Biosciences, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
CARIBOU BIOSCIENCES ($CRBU) Releases Q2 2026 Earnings - Quiver Quantitative
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):